| Molecular portraits of human breast tumours CM Perou, T Sørlie, MB Eisen, M Van De Rijn, SS Jeffrey, CA Rees, ... nature 406 (6797), 747-752, 2000 | 19955 | 2000 |
| Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma TO Nielsen, FD Hsu, K Jensen, M Cheang, G Karaca, Z Hu, ... Clinical cancer research 10 (16), 5367-5374, 2004 | 3662 | 2004 |
| Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer WD Foulkes, IM Stefansson, PO Chappuis, LR Bégin, JR Goffin, N Wong, ... Journal of the national cancer institute 95 (19), 1482-1485, 2003 | 1306 | 2003 |
| Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 … FM Blows, KE Driver, MK Schmidt, A Broeks, FE Van Leeuwen, ... PLoS medicine 7 (5), e1000279, 2010 | 1249 | 2010 |
| EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast IM Bachmann, OJ Halvorsen, K Collett, IM Stefansson, O Straume, ... J Clin Oncol 24 (2), 268-273, 2006 | 1018 | 2006 |
| Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients T Aas, AL Børresen, S Geisler, B Smith-Sørensen, H Johnsen, ... Nature medicine 2 (7), 811-814, 1996 | 957 | 1996 |
| Landscape of genomic alterations in cervical carcinomas AI Ojesina, L Lichtenstein, SS Freeman, CS Pedamallu, ... Nature 506 (7488), 371-375, 2014 | 829 | 2014 |
| Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes EA Rakha, SE Elsheikh, MA Aleskandarany, HO Habashi, AR Green, ... Clinical Cancer Research 15 (7), 2302-2310, 2009 | 661 | 2009 |
| A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer K Gravdal, OJ Halvorsen, SA Haukaas, LA Akslen Clinical cancer research 13 (23), 7003-7011, 2007 | 658 | 2007 |
| Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival C Gjerdrum, C Tiron, T Høiby, I Stefansson, H Haugen, T Sandal, K Collett, ... Proceedings of the National Academy of Sciences 107 (3), 1124-1129, 2010 | 648 | 2010 |
| Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch GN Naumov, LA Akslen, J Folkman Cell cycle 5 (16), 1779-1787, 2006 | 592 | 2006 |
| Use of immunohistochemical markers can refine prognosis in triple negative breast cancer M Tischkowitz, JS Brunet, LR Bégin, DG Huntsman, MCU Cheang, ... BMC cancer 7, 1-11, 2007 | 563 | 2007 |
| The Prognostic Implication of the Basal-Like (Cyclin Ehigh/p27low/p53+/Glomeruloid-Microvascular-Proliferation+) Phenotype of BRCA1-Related Breast Cancer WD Foulkes, JS Brunet, IM Stefansson, O Straume, PO Chappuis, ... Cancer research 64 (3), 830-835, 2004 | 517 | 2004 |
| A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype GN Naumov, E Bender, D Zurakowski, SY Kang, D Sampson, E Flynn, ... Journal of the National Cancer Institute 98 (5), 316-325, 2006 | 507 | 2006 |
| Influence of TP53 Gene Alterations and c-erbB-2 Expression on the Response to Treatment with Doxorubicin in Locally Advanced Breast Cancer S Geisler, PE Lønning, T Aas, H Johnsen, Ø Fluge, DF Haugen, ... Cancer research 61 (6), 2505-2512, 2001 | 450 | 2001 |
| Drug-sensitive FGFR2 mutations in endometrial carcinoma A Dutt, HB Salvesen, TH Chen, AH Ramos, RC Onofrio, C Hatton, ... Proceedings of the National Academy of Sciences 105 (25), 8713-8717, 2008 | 414 | 2008 |
| PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma HB Salvesen, N MacDonald, A Ryan, IJ Jacobs, ED Lynch, LA Akslen, ... International journal of cancer 91 (1), 22-26, 2001 | 411 | 2001 |
| Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistance GN Naumov, MB Nilsson, T Cascone, A Briggs, O Straume, LA Akslen, ... Clinical Cancer Research 15 (10), 3484-3494, 2009 | 365 | 2009 |
| Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer. K Collett, GE Eide, J Arnes, IM Stefansson, J Eide, A Braaten, T Aas, ... Clinical cancer research: an official journal of the American Association …, 2006 | 362 | 2006 |
| Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation HB Salvesen, SL Carter, M Mannelqvist, A Dutt, G Getz, IM Stefansson, ... Proceedings of the National Academy of Sciences 106 (12), 4834-4839, 2009 | 352 | 2009 |
